過体重または肥満に苦しむ人々に対するNNC0174-0833の有効性を調査する研究。

基本情報

NCT ID

NCT03856047

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

706

治験依頼者名

Novo Nordisk A/S

概要

This study will look at the change in body weight in people taking NNC0174-0833, liraglutide and "dummy" medicine, from the start to the end of the study. As well as taking the medicine, participants will have talks with study staff about healthy food choices, how to be more physically active and what participants can do to lose weight. Participants will either take NNC0174-0833, liraglutide or "dummy" medicine - which treatment participants get is decided by chance. Participants will need to take one injection once a week or once a day, depending on the treatment. The study medicine is injected with a thin needle in a skin fold in the stomach, thigh or upper arm. The study will last for about 8 months. Participants will have 12 clinic visits with the study doctor.

対象疾患

介入

依頼者（Sponsor）

実施施設 (3)